Compugen Revenues Slide | GenomeWeb

NEW YORK, Feb. 5 – Compgen today reported revenue decreases for the fourth quarter and for the year today.

The Tel Aviv, Israel-based company saw revenues fall to $11.1 million in 2002 from $11.4 million for 2001, and $2.7 million in the fourth quarter compared to $3.1 million for the year-ago quarter.

The company said it began 2003 with $67.3 million in cash and cash-related accounts with an anticipated burn rate for 2003 of $15.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.